Mean values and 95% confidence intervals for recovery time, Average NN Interval (AVNN); Standard Deviation of NN Intervals (SDNN), Low Frequency/ High Frequency Ratio (LF/HF); and... by Robert Trybulski (10998702)

Changes in wavelet index, pain threshold index, mean arterial pressure and heart rate (mean ±SD) between two groups. by Guangquan An (11473126)

Subjects:

Change in Mean Anxiety Scores Over time by group. by Shaaista Budhani (21030221)

“…There was a trend of increased recall rates in group 2 for short-term problems, long-term problems, intervention, and incidence rates, but it did not reach statistically significant level. …”

Changes in arterial oxygen partial pressure, lactic and blood glucose with blood gas (mean±SD) between two groups. by Guangquan An (11473126)

Subjects:

Summary of PTI and WLI with repeated measurement (mean, 95% CI). by Guangquan An (11473126)

Subjects:

NN analysis to assign the importance of variables. by Sulmaz Ghahramani (3387635)

Calibration curve for external validation in the validation group. by Ying Zheng (170527)

Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during letrozole treatment. by Kazuyoshi Ohkawa (836847)

Subjects:

Flowchart of patient selection in this study. by Kazuyoshi Ohkawa (836847)

Subjects:

Changes in the FIB-4 index in breast cancer patients with a FIB-4 index of ≥ 2.67 during letrozole and anastrozole treatment. by Kazuyoshi Ohkawa (836847)

Subjects:

Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during anastrozole treatment. by Kazuyoshi Ohkawa (836847)

Subjects:

Clinical features and cancer treatment in patients with breast cancer receiving letrozole and anastrozole. by Kazuyoshi Ohkawa (836847)

Subjects:

S1 Data - by Kazuyoshi Ohkawa (836847)

Subjects:

Clinical course of patient no. by Kazuyoshi Ohkawa (836847)

Subjects:

Incidence of New-Onset Cardiovascular Disease in 2018 Follow-up by Sleep Duration Groups. by Zhi Jin (3742471)

Subjects:

Total Gaze-Validated objects in the VE. by Leah R. Enders (18536102)

“…<p>The Active Duty group saw significantly greater numbers of Gaze-Validated Targets (b). …”

Summary of PaO₂, lactic and blood glucose with repeated measurement (mean, 95% CI). by Guangquan An (11473126)

Subjects:

Summary of the effect of MPDD on SDLP across all participants, and also participants categorized by driving styles (“NS” (no significant), “+” (significant increase), and “-” (sign... by Mobina Faqani (22783963)

Column charts of WiAUC in therapy and control group at baseline and follow-up. by Felix L. Herr (21544362)

Subjects:

ROC curve of validation group. by Ying Zheng (170527)